Real-time Quantitative Optical Perfusion Imaging in Surgery

February 6, 2018 updated by: S.S. Gisbertz, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Real-time Quantitative Optical Perfusion Imaging in Surgery: a Prospective, Observational, In-vivo, Human, Single-center Study

Surgeons are nowadays unable to visualize and quantitatively evaluate microvascularisation in real-time during surgery. Complications due to vascular compromise are a major problem, especially in reconstructive surgery. Poor blood perfusion leads to ischemia and even tissue necrosis. If, however, perfusion and ischemia could be monitored during surgery, then surgeons could change their reconstructive design and the anaesthesiologists could improve perfusion with fluids, inotropes or vasopressors, if necessary. Surgeons therefore need a tool that is able to image in high resolution (microvascularisation), direct, intra-operative, in 3D (to image thrombosis, luminal narrowing or distinct overlaying vessels) and that produces quantitative data to objectify image interpretation.

Optical techniques, based on the interaction of light with tissue, are able to image tissue at high resolution and in real-time. These techniques are FDA-approved and have emerged as powerful diagnostic tools in different departments of medicine, such as ophthalmology for visualizing retina vascularisation and dermatology for skin diagnostics.

In this study, investigators hypothesize that four novel optical technologies: Fluorescence Imaging, Laser Speckle Contrast Imaging, Optical Coherence Tomography and Sidestream Darkfield Microscopy are able to quantitatively image perfusion in real-time during surgery.

Study Overview

Status

Completed

Detailed Description

Primary objective - Perfusion will be measured with all the techniques focussed on 4 areas; from 'good' to 'decreased' perfusion (biologically)

Fluorescence Imaging (FI): Time to intensity measurements at four sides Laser Speckle Contrast Imaging (LSCI): Perfusion Units Optical Coherence Tomography (OCT): Vessel density & decorrelation time Sidestream Darkfield Microscopy (SDF): Total vessel density, proportion of perfused vessels, perfused vessel density, max flow index, De Backer score, perfusion in mm/sec.

Differences in parameters between the four sites will be statistically be compared.

Secondary objectives

- Relation of parameters to patient outcome in terms of adverse events.

Study Type

Observational

Enrollment (Actual)

26

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Amsterdam, Netherlands, 1105 AZ
        • Academic Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Adult patients receiving reconstructive surgical treatment in the Academic Medical Center: 20 patients receiving free flap reconstructive surgery, and 20 patients receiving thoracolaparoscopic esophagectomy with gastric tube reconstruction. Patients will be selected irrespective of medical history, ethnic background or gender, stated that a physician of the department of Biomedical Engineering and Physics is available at time of surgery.

Description

Inclusion Criteria:

  • Age ≥ 18 years - Scheduled for reconstructive surgery with free flap reconstruction or laparoscopic transhiatal and 3-stage transthoracic gastric tube surgery.

Exclusion Criteria:

  • Allergic to iodide (indocyanine green)
  • Hyper-thyroidism
  • Breastfeeding
  • No informed consent
  • Allergic to ephedrine
  • Ischaemic heart disease
  • Thyrotoxicosis
  • Autonomic thyroid adenomas
  • Intraoperative hypertension or tachycardia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with OCT.
Time Frame: 1 year
- Perfusion will be imaged with OCT and measured in total vessel density.
1 year
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with SDF.
Time Frame: 1 year
Perfusion will be imaged with SDF and measured in microvascular flow index.
1 year
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with LSCI.
Time Frame: 1 year
flux in perfusion units (LSCI)
1 year
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with FI.
Time Frame: 1 year
intensity/time (FI)
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with treatment-related adverse events as assessed by CTCAE v4.0
Time Frame: 1 year
1 year
Distance of watershed to fundus (GT) or artery to tip (flap)
Time Frame: 1 year
In the FI images the distance between the end of the right gastroepiploic artery and the fundus, and the distance between the artery entry and tip of the flap can be calculated.
1 year
Measurement-time during surgery
Time Frame: 30 minutes
time in minutes will be calculated during measurements
30 minutes
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with OCT.
Time Frame: 1 year
- Perfusion will be imaged with OCT and measured in decorrelation time.
1 year
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with SDF.
Time Frame: 1 year
Perfusion will be imaged with SDF and measured in total vessel density.
1 year
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with SDF.
Time Frame: 1 year
Perfusion will be imaged with SDF and measured in perfused vessel density.
1 year
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with SDF.
Time Frame: 1 year
Perfusion will be imaged with SDF and measured in proportion of perfused vessels.
1 year
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with SDF.
Time Frame: 1 year
Perfusion will be imaged with SDF and measured in De Backer Score.
1 year
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with SDF.
Time Frame: 1 year
Perfusion will be imaged with SDF and measured in velocity in mm/sec.
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2015

Primary Completion (Actual)

September 1, 2016

Study Completion (Actual)

December 1, 2017

Study Registration Dates

First Submitted

January 24, 2016

First Submitted That Met QC Criteria

September 12, 2016

First Posted (Estimate)

September 16, 2016

Study Record Updates

Last Update Posted (Actual)

February 7, 2018

Last Update Submitted That Met QC Criteria

February 6, 2018

Last Verified

February 1, 2018

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Complications of Perfusion

Subscribe